Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0Q5TH
|
||||
| Former ID |
DIB013238
|
||||
| Drug Name |
XR-5944
|
||||
| Synonyms |
MLN-944; XR-11576 analogs; XR-5000 analogs; XR-5942
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Gastric cancer [ICD9: 151; ICD10:C16] | Phase 1 | [1] | ||
| Company |
Xenova Group plc
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C34H34N8O2
|
||||
| Canonical SMILES |
n1c2c(C(=O)NCCNCCNCCNC(=O)c3c4nc5c(nc4ccc3)cccc5C)cccc2<br />nc2c1c(ccc2)C
|
||||
| CAS Number |
CAS 343247-32-5
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | DNA topoisomerase II | Target Info | Modulator | [1] | |
| References | |||||
| REF 1 | Antitumor activity of XR5944, a novel and potent topoisomerase poison. Anticancer Drugs. 2001 Apr;12(4):359-67. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.